BML Pharmaceuticals Inc. acquired by Endo Pharmaceuticals Inc.
|
|
|
|
|
products are formulated into therapeutics that range from the prevention and treatment of dermal disease to the severely debilitating mucositis that is a major dose-limiting factor in radiation and chemotherapy treatment for cancer patients | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|